Register entry
- Registered sites
- 1
- Active NDC listings
- 18
- Live patents
- 0
- Countries
- 1
- Base
- France
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Guerlain | 4 AVENUE GUSTAVE EIFFEL, Chartres, 28000, France (FRA) | Finished drug manufacture | 3005718129266623064 |
Catalogue
Drug listings by form and route
1818 active NDC listings: 18 human otc drug. By marketing category: OTC MONOGRAPH DRUG 18.
| Dosage form | NDCs |
|---|---|
| emulsion | 18 |
| Route | NDCs |
|---|---|
| topical | 18 |
| Labeller name on the listing | NDCs |
|---|---|
| guerlain | 18 |
Catalogue
Marketed products
18| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 0.5C | OCTISALATE, TITANIUM DIOXIDE | emulsion, topical | 49817-2063OTC MONOGRAPH DRUG |
| PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 0.5N | OCTISALATE, TITANIUM DIOXIDE | emulsion, topical | 49817-2064OTC MONOGRAPH DRUG |
| PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 0C | OCTISALATE, TITANIUM DIOXIDE | emulsion, topical | 49817-2080OTC MONOGRAPH DRUG |
| PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 0N | OCTISALATE, TITANIUM DIOXIDE | emulsion, topical | 49817-2065OTC MONOGRAPH DRUG |
| PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 1.5N | OCTISALATE, TITANIUM DIOXIDE | emulsion, topical | 49817-2066OTC MONOGRAPH DRUG |
| PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 1C | OCTISALATE, TITANIUM DIOXIDE | emulsion, topical | 49817-2067OTC MONOGRAPH DRUG |
| PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 1N | OCTISALATE, TITANIUM DIOXIDE | emulsion, topical | 49817-2068OTC MONOGRAPH DRUG |
| PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 2N | OCTISALATE, TITANIUM DIOXIDE | emulsion, topical | 49817-2069OTC MONOGRAPH DRUG |
| PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 2W | OCTISALATE, TITANIUM DIOXIDE | emulsion, topical | 49817-2070OTC MONOGRAPH DRUG |
| PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 3.5N | OCTISALATE, TITANIUM DIOXIDE | emulsion, topical | 49817-2071OTC MONOGRAPH DRUG |
| PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 3N | OCTISALATE, TITANIUM DIOXIDE | emulsion, topical | 49817-2072OTC MONOGRAPH DRUG |
| PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 3W | OCTISALATE, TITANIUM DIOXIDE | emulsion, topical | 49817-2073OTC MONOGRAPH DRUG |
| PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 4N | OCTISALATE, TITANIUM DIOXIDE | emulsion, topical | 49817-2074OTC MONOGRAPH DRUG |
| PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 4W | OCTISALATE, TITANIUM DIOXIDE | emulsion, topical | 49817-2075OTC MONOGRAPH DRUG |
| PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 5N | OCTISALATE, TITANIUM DIOXIDE | emulsion, topical | 49817-2076OTC MONOGRAPH DRUG |
| PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 6N | OCTISALATE, TITANIUM DIOXIDE | emulsion, topical | 49817-2077OTC MONOGRAPH DRUG |
| PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 7N | OCTISALATE, TITANIUM DIOXIDE | emulsion, topical | 49817-2078OTC MONOGRAPH DRUG |
| PARURE GOLD SKIN MATTE FOUNDATION NO-TRANSFER HIGH PERFECTION 24H CARE AND WEAR INFUSED WITH 24K GOLD AND WHITE PEONY WITH SUNSCREEN BROADSPECTRUM SPF 15 8N | OCTISALATE, TITANIUM DIOXIDE | emulsion, topical | 49817-2079OTC MONOGRAPH DRUG |
Compare
Comparable companies in France
- Parfums Christian Dior1 site · 224 NDC
- Sevene SAS1 site · 154 NDC
- BCM Cosmetique1 site · 72 NDC
- Recordati Rare Diseases1 site · 21 NDC
- OPELLA HEALTHCARE INTERNATIONAL SAS1 site · 17 NDC
- Valdepharm1 site · 17 NDC
- Septodont SAS1 site · 15 NDC
- Laboratoires Clarins1 site · 14 NDC
- Meribel Pharma Pessac1 site · 8 NDC
- Laboratoires Expanscience1 site · 7 NDC
Enquiry
Common questions
- Is Guerlain FDA approved?
- Guerlain holds 1 FDA-registered establishment in France. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Guerlain's drugs manufactured?
- The FDA register lists Chartres. Registered operations: finished drug manufacture.
- What drugs does Guerlain make?
- 18 products are listed under Guerlain in the openFDA NDC Directory, most often as emulsion. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.